Likewise, there was no significant upregulation of PD-L1 or PD-L2 tumor mRNA or serum protein (Figure S3B), although responders had significantly higher PD-L2 mRNA in the tumor post-therapy (Figure S3C). Here, CD274 is linked to neoplasm.